Literature DB >> 20220776

Relevant mouse model for human monocytic leukemia through Cre/lox-controlled myeloid-specific deletion of PTEN.

H Yu, Y Li, C Gao, L Fabien, Y Jia, J Lu, L E Silberstein, G S Pinkus, K Ye, L Chai, H R Luo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20220776      PMCID： PMC4134872          DOI： 10.1038/leu.2010.34

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.

Authors:  Jiwang Zhang; Justin C Grindley; Tong Yin; Sachintha Jayasinghe; Xi C He; Jason T Ross; Jeffrey S Haug; Dawn Rupp; Kimberly S Porter-Westpfahl; Leanne M Wiedemann; Hong Wu; Linheng Li
Journal:  Nature       Date:  2006-04-23       Impact factor: 49.962

2.  Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential.

Authors:  Min Ye; Hiromi Iwasaki; Catherine V Laiosa; Matthias Stadtfeld; Huafeng Xie; Susanne Heck; Bjorn Clausen; Koichi Akashi; Thomas Graf
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

3.  Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions.

Authors:  Kulandayan K Subramanian; Yonghui Jia; Daocheng Zhu; Benjamin T Simms; Hakryul Jo; Hidenori Hattori; Jian You; Joseph P Mizgerd; Hongbo R Luo
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

Review 4.  Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.

Authors:  A M Martelli; M Nyåkern; G Tabellini; R Bortul; P L Tazzari; C Evangelisti; L Cocco
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

5.  Deactivation of phosphatidylinositol 3,4,5-trisphosphate/Akt signaling mediates neutrophil spontaneous death.

Authors:  Daocheng Zhu; Hidenori Hattori; Hakryul Jo; Yonghui Jia; Kulandayan K Subramanian; Fabien Loison; Jian You; Yi Le; Marek Honczarenko; Leslie Silberstein; Hongbo R Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-20       Impact factor: 11.205

6.  Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice.

Authors:  Chaitali Parikh; Ramesh Subrahmanyam; Ruibao Ren
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

7.  Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.

Authors:  Omer H Yilmaz; Riccardo Valdez; Brian K Theisen; Wei Guo; David O Ferguson; Hong Wu; Sean J Morrison
Journal:  Nature       Date:  2006-04-05       Impact factor: 49.962

8.  Targeted deletion of tumor suppressor PTEN augments neutrophil function and enhances host defense in neutropenia-associated pneumonia.

Authors:  Yitang Li; Yonghui Jia; Muriel Pichavant; Fabien Loison; Bara Sarraj; Anongnard Kasorn; Jian You; Bryanne E Robson; Dale T Umetsu; Joseph P Mizgerd; Keqiang Ye; Hongbo R Luo
Journal:  Blood       Date:  2009-03-13       Impact factor: 22.113
  8 in total
  10 in total

1.  Pretreatment with phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670 augments the efficacy of granulocyte transfusion in a clinically relevant mouse model.

Authors:  Yitang Li; Amit Prasad; Yonghui Jia; Saurabh Ghosh Roy; Fabien Loison; Subhanjan Mondal; Paulina Kocjan; Leslie E Silberstein; Sheng Ding; Hongbo R Luo
Journal:  Blood       Date:  2011-04-26       Impact factor: 22.113

2.  Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy.

Authors:  Y Lucy Liu; Yan Yan; Cody Webster; Lijian Shao; Shelly Y Lensing; Hongyu Ni; Wei Feng; Natalia Colorado; Rupak Pathak; Zhifu Xiang; Martin Hauer-Jensen; Shaoguang Li; Daohong Zhou; Peter D Emanuel
Journal:  Blood       Date:  2016-01-13       Impact factor: 22.113

Review 3.  Animal models of leukemia: any closer to the real thing?

Authors:  Guerry J Cook; Timothy S Pardee
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

4.  Multifaceted roles of PTEN and TSC orchestrate growth and differentiation of Drosophila blood progenitors.

Authors:  Michelle Dragojlovic-Munther; Julian A Martinez-Agosto
Journal:  Development       Date:  2012-09-05       Impact factor: 6.868

5.  Differential roles of Kras and Pten in murine leukemogenesis.

Authors:  P Tang; C Gao; A Li; J Aster; L Sun; L Chai
Journal:  Leukemia       Date:  2012-11-07       Impact factor: 11.528

6.  B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells.

Authors:  Wei Zhang; Jing Wang; Yanfang Wang; Fei Dong; Mingxia Zhu; Wenli Wan; Haishen Li; Feifei Wu; Xinxing Yan; Xiaoyan Ke
Journal:  Onco Targets Ther       Date:  2015-07-14       Impact factor: 4.147

7.  Warburg effect and translocation-induced genomic instability: two yeast models for cancer cells.

Authors:  Valentina Tosato; Nana-Maria Grüning; Michael Breitenbach; Remigiusz Arnak; Markus Ralser; Carlo V Bruschi
Journal:  Front Oncol       Date:  2013-01-18       Impact factor: 6.244

Review 8.  Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment.

Authors:  Alberto M Martelli; Francesca Chiarini; Camilla Evangelisti; Alessandra Cappellini; Francesca Buontempo; Daniela Bressanin; Milena Fini; James A McCubrey
Journal:  Oncotarget       Date:  2012-04

9.  Akt-induced phosphorylation of N-CoR at serine 1450 contributes to its misfolded conformational dependent loss (MCDL) in acute myeloid leukemia of the M5 subtype.

Authors:  Dawn Sijin Nin; Azhar Bin Ali; Koichi Okumura; Norio Asou; Chien-Shing Chen; Wee Joo Chng; Matiullah Khan
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  The emerging role of the phosphatidylinositol 3-kinase/ akt/mammalian target of rapamycin signaling network in cancer stem cell biology.

Authors:  Alberto M Martelli; Camilla Evangelisti; Francesca Chiarini; Cecilia Grimaldi; James A McCubrey
Journal:  Cancers (Basel)       Date:  2010-08-18       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.